Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Brentuximab vedotin chemotherapy can cause long-term hair loss and emotional distress.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

The A allele of the C2 gene increases the risk of lupus, while the G allele may protect against it.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The study aims to find new risk factors and early signs for heart and brain diseases to improve prevention and management.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

3D imaging effectively tracks skin changes in vitiligo treatment.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Intralesional corticosteroids are best for mild alopecia areata, and DPCP is best for severe cases.

Young patients with alopecia areata are satisfied with Janus kinase inhibitors, noting hair regrowth and improved quality of life.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Sublingual and oral minoxidil are equally effective for hair growth, but sublingual causes fewer palpitations.

The steroids allopregnanolone and allotetrahydrodeoxycorticosteron worsened absence seizures in rats.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

The 2% minoxidil nanosuspension is as effective as the commercial product but safer and easier to use.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.